IL17A and psoriasis: In psoriasis, an increased production of IL-23 and IL-17 produces a self-amplifying inflammatory response in keratinocytes, leading to epidermal hyperplasia, epidermal cell proliferation, and the recruitment of leukocyte subsets into the skin [4].